Remedium Life

Market Cap: Micro Cap
Industry: Trading
ISIN: INE549S01036
NSEID:
BSEID: 539561

INR

2.22

0.04 (1.83%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.0 lacs

{
  "main_header": {
    "sid": 857841,
    "name": "Remedium Life",
    "stock_name": "Remedium Life",
    "full_name": "Remedium Lifecare Ltd",
    "name_url": "stocks-analysis/remedium-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.22",
    "chg": 0.04,
    "chgp": "1.83%",
    "dir": 1,
    "prev_price": "2.18",
    "mcapval": "89.51 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539561,
    "symbol": "",
    "ind_name": "Trading",
    "ind_code": 49,
    "isin": "INE549S01036",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:14 AM",
    "bse_nse_vol": "6.0 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/remedium-life-857841-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Remedium Lifecare Ltd Sees Strong Buying Momentum Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-ltd-surges-5-00-today-marking-third-consecutive-day-of-gains-1693571",
        "imagepath": "",
        "date": "2025-04-03 09:35:38",
        "description": "Remedium Lifecare Ltd is currently witnessing significant buying activity, with the stock gaining 5.00% today, contrasting sharply with the Sensex's decline of 0.58%. Over the past week, Remedium Lifecare has shown a robust performance, rising 9.95%, while the Sensex has decreased by 1.85%. Notably, the stock has experienced consecutive gains over the last three days, accumulating a total return of 15.38%.\n\nDespite this recent uptick, Remedium Lifecare's longer-term performance reveals challenges, with a 93.16% decline over the past year compared to a 3.11% increase in the Sensex. However, the stock has demonstrated resilience over a three-year period, with a gain of 75.82%, significantly outperforming the Sensex's 28.50% rise.\n\nToday's trading session opened with a gap up, and the stock's intraday high reflects the strong buying momentum. The stock is currently trading above its 5-day moving average but re..."
      },
      {
        "title": "Remedium Lifecare Ltd Experiences Notable Buying Surge Amid Ongoing Price Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-ltd-surges-4-71-today-marking-second-consecutive-day-of-gains-1671783",
        "imagepath": "",
        "date": "2025-04-02 09:35:39",
        "description": "Remedium Lifecare Ltd is currently witnessing significant buying activity, with the stock gaining 4.71% today, outperforming the Sensex, which rose by 0.54%. This marks the second consecutive day of gains for Remedium Lifecare, with a total increase of 9.89% over this period. Despite this recent uptick, the stock has faced challenges over the longer term, showing a decline of 24.81% over the past month and a staggering 93.29% drop over the past year.\n\nIn terms of price performance, Remedium Lifecare opened with a gap up, indicating strong initial buying interest. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the longer term. \n\nThe buying pressure could be attributed to various factors, including market sentiment and potential developments within the trading sector. However, the stock's performance remains significantly low..."
      },
      {
        "title": "Remedium Lifecare's Decline Highlights Risks in Microcap Stock Investments",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-hits-52-week-low-amid-93-27-annual-stock-decline-1661221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/RemediumLifecar_priceRelatedfactors_853290.png",
        "date": "2025-04-01 11:55:19",
        "description": "Remedium Lifecare has hit a new 52-week low, reflecting a 93.27% decline over the past year. The company reported severe financial setbacks, including a drastic drop in operating profit and net sales, alongside a high debt-to-EBITDA ratio, highlighting ongoing challenges in its financial health."
      },
      {
        "title": "Remedium Lifecare Faces Severe Financial Struggles Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-hits-52-week-low-amidst-93-27-stock-decline-and-losses-1661216",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/RemediumLifecar_priceRelatedfactors_853293.png",
        "date": "2025-04-01 11:55:13",
        "description": "Remedium Lifecare has reached a new 52-week low, reflecting a significant decline of 93.27% over the past year. The company reported a drastic drop in operating profit and net sales, alongside a concerning debt-to-EBITDA ratio. Its performance contrasts sharply with the broader market's recent downturn."
      },
      {
        "title": "Remedium Lifecare Faces Severe Financial Struggles Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-hits-52-week-low-amid-significant-financial-declines-and-losses-1661217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/RemediumLifecar_priceRelatedfactors_853292.png",
        "date": "2025-04-01 11:55:12",
        "description": "Remedium Lifecare has reached a new 52-week low, experiencing a significant decline over the past year, contrasting with the broader market's modest gains. The company faces serious financial challenges, including a drastic drop in operating profit and net sales, alongside a high debt-to-EBITDA ratio, indicating weak fundamentals."
      },
      {
        "title": "Remedium Lifecare Faces Severe Financial Struggles Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-hits-52-week-low-as-stock-declines-93-27-over-past-year-1661214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/RemediumLifecar_priceRelatedfactors_853294.png",
        "date": "2025-04-01 11:55:12",
        "description": "Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 93.27% decline in performance over the past year. The company reported a drastic drop in net sales and operating profit, alongside a concerning debt-to-EBITDA ratio, indicating difficulties in servicing its debt obligations."
      },
      {
        "title": "Remedium Lifecare Ltd Sees Significant Buying Activity Amidst Recent Price Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-ltd-rises-4-95-today-ending-four-day-decline-amid-broader-market-drop-1660633",
        "imagepath": "",
        "date": "2025-04-01 11:45:12",
        "description": "Remedium Lifecare Ltd is currently witnessing significant buying activity, marking a notable performance shift after four consecutive days of decline. Today, the stock surged by 4.95%, contrasting sharply with the Sensex, which fell by 1.66%. This uptick comes as a relief for investors, especially considering the stock's recent struggles, including a 28.20% drop over the past month and a staggering 93.27% decline over the past year.\n\nThe stock opened at a new 52-week low of Rs. 1.73, indicating a potential trend reversal. Despite this day's gains, Remedium Lifecare remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting ongoing challenges in regaining upward momentum. \n\nThe trading sector overall has seen a 3.42% increase, which may have contributed to the buying pressure on Remedium Lifecare. The stock's performance relative to the Sensex highlights its volatility, with a ..."
      },
      {
        "title": "Remedium Lifecare's Quality Grade Change Reflects Mixed Financial Performance and Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-downgraded-to-below-average-quality-grade-amid-financial-struggles-1656338",
        "imagepath": "",
        "date": "2025-04-01 08:00:04",
        "description": "Remedium Lifecare has recently undergone an evaluation revision, reflecting notable shifts in its financial metrics. The company, operating within the trading industry, has demonstrated significant sales growth over the past five years, achieving a remarkable 269.49%. However, this positive aspect is contrasted by a substantial decline in EBIT growth, which stands at -303.30%. \n\nThe company's financial health is further illustrated by its average EBIT to interest ratio of -11.47 and a debt to EBITDA ratio of 4.16, indicating potential challenges in managing its debt levels. Additionally, the net debt to equity ratio is recorded at 1.61, suggesting a reliance on debt financing. \n\nIn terms of performance indicators, Remedium Lifecare's return on equity (ROE) is notably high at 68.04%, while its return on capital employed (ROCE) is relatively low at 1.07%. The company's tax ratio is also significant at 63.95%...."
      },
      {
        "title": "Remedium Lifecare Faces Intense Selling Pressure Amid Significant Stock Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/remedium-lifecare-ltd-faces-heavy-selling-pressure-stock-drops-4-71-to-all-time-low-of-rs-1-82-1640212",
        "imagepath": "",
        "date": "2025-03-28 10:00:12",
        "description": "Remedium Lifecare Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with its stock price dropping by 4.71% in just one day, compared to a modest 0.22% decline in the Sensex. Over the past week, Remedium Lifecare has lost 16.13%, while the Sensex has gained 0.69%. \n\nThe stock's performance over the last month is particularly concerning, with a staggering 31.58% drop, contrasting sharply with the Sensex's increase of 5.79%. Year-to-date, Remedium Lifecare has plummeted by 64.45%, while the Sensex has only dipped by 0.90%. The stock has now reached a new 52-week and all-time low of Rs. 1.82, reflecting a significant underperformance against its sector by 4%.\n\nThis marks the fourth consecutive day of losses for Remedium Lifecare, with a total decline of 16.67% during this period. The stock is trading below its 5-day, 2..."
      }
    ],
    "total": 139,
    "sid": "857841",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/remedium-lifecare-857841"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "08-Apr-2025",
      "details": "Press Release - Remedium Lifecare Announces ?49.19 Cr Rights Issue for Expansion",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On April 07 2025",
      "datetime": "07-Apr-2025",
      "details": "Outcome of Board Meeting held on April 07 2025 for 1)Considering approving and fixing Tuesday 15 April 2025 as the Record Date for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue; 2) Considering and approving the terms of the right issue.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>1:5</strong> stock split, ex-date: 23 Feb 24",
          "dt": "2024-02-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 05 Jul 24",
          "dt": "2024-07-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>61:50</strong> rights issue, ex-date: 15 Apr 25",
          "dt": "2025-04-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Remedium Lifecare Ltd Sees Strong Buying Momentum Amid Broader Market Decline

2025-04-03 09:35:38

Remedium Lifecare Ltd is currently witnessing significant buying activity, with the stock gaining 5.00% today, contrasting sharply with the Sensex's decline of 0.58%. Over the past week, Remedium Lifecare has shown a robust performance, rising 9.95%, while the Sensex has decreased by 1.85%. Notably, the stock has experienced consecutive gains over the last three days, accumulating a total return of 15.38%. Despite this recent uptick, Remedium Lifecare's longer-term performance reveals challenges, with a 93.16% decline over the past year compared to a 3.11% increase in the Sensex. However, the stock has demonstrated resilience over a three-year period, with a gain of 75.82%, significantly outperforming the Sensex's 28.50% rise. Today's trading session opened with a gap up, and the stock's intraday high reflects the strong buying momentum. The stock is currently trading above its 5-day moving average but re...

Remedium Lifecare Ltd Experiences Notable Buying Surge Amid Ongoing Price Challenges

2025-04-02 09:35:39

Remedium Lifecare Ltd is currently witnessing significant buying activity, with the stock gaining 4.71% today, outperforming the Sensex, which rose by 0.54%. This marks the second consecutive day of gains for Remedium Lifecare, with a total increase of 9.89% over this period. Despite this recent uptick, the stock has faced challenges over the longer term, showing a decline of 24.81% over the past month and a staggering 93.29% drop over the past year. In terms of price performance, Remedium Lifecare opened with a gap up, indicating strong initial buying interest. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the longer term. The buying pressure could be attributed to various factors, including market sentiment and potential developments within the trading sector. However, the stock's performance remains significantly low...

Remedium Lifecare's Decline Highlights Risks in Microcap Stock Investments

2025-04-01 11:55:19

Remedium Lifecare has hit a new 52-week low, reflecting a 93.27% decline over the past year. The company reported severe financial setbacks, including a drastic drop in operating profit and net sales, alongside a high debt-to-EBITDA ratio, highlighting ongoing challenges in its financial health.

Remedium Lifecare Faces Severe Financial Struggles Amid Broader Market Decline

2025-04-01 11:55:13

Remedium Lifecare has reached a new 52-week low, reflecting a significant decline of 93.27% over the past year. The company reported a drastic drop in operating profit and net sales, alongside a concerning debt-to-EBITDA ratio. Its performance contrasts sharply with the broader market's recent downturn.

Remedium Lifecare Faces Severe Financial Struggles Amid Broader Market Challenges

2025-04-01 11:55:12

Remedium Lifecare has reached a new 52-week low, experiencing a significant decline over the past year, contrasting with the broader market's modest gains. The company faces serious financial challenges, including a drastic drop in operating profit and net sales, alongside a high debt-to-EBITDA ratio, indicating weak fundamentals.

Remedium Lifecare Faces Severe Financial Struggles Amid Broader Market Decline

2025-04-01 11:55:12

Remedium Lifecare has faced significant challenges, hitting a new 52-week low and experiencing a 93.27% decline in performance over the past year. The company reported a drastic drop in net sales and operating profit, alongside a concerning debt-to-EBITDA ratio, indicating difficulties in servicing its debt obligations.

Remedium Lifecare Ltd Sees Significant Buying Activity Amidst Recent Price Volatility

2025-04-01 11:45:12

Remedium Lifecare Ltd is currently witnessing significant buying activity, marking a notable performance shift after four consecutive days of decline. Today, the stock surged by 4.95%, contrasting sharply with the Sensex, which fell by 1.66%. This uptick comes as a relief for investors, especially considering the stock's recent struggles, including a 28.20% drop over the past month and a staggering 93.27% decline over the past year. The stock opened at a new 52-week low of Rs. 1.73, indicating a potential trend reversal. Despite this day's gains, Remedium Lifecare remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting ongoing challenges in regaining upward momentum. The trading sector overall has seen a 3.42% increase, which may have contributed to the buying pressure on Remedium Lifecare. The stock's performance relative to the Sensex highlights its volatility, with a ...

Remedium Lifecare's Quality Grade Change Reflects Mixed Financial Performance and Challenges

2025-04-01 08:00:04

Remedium Lifecare has recently undergone an evaluation revision, reflecting notable shifts in its financial metrics. The company, operating within the trading industry, has demonstrated significant sales growth over the past five years, achieving a remarkable 269.49%. However, this positive aspect is contrasted by a substantial decline in EBIT growth, which stands at -303.30%. The company's financial health is further illustrated by its average EBIT to interest ratio of -11.47 and a debt to EBITDA ratio of 4.16, indicating potential challenges in managing its debt levels. Additionally, the net debt to equity ratio is recorded at 1.61, suggesting a reliance on debt financing. In terms of performance indicators, Remedium Lifecare's return on equity (ROE) is notably high at 68.04%, while its return on capital employed (ROCE) is relatively low at 1.07%. The company's tax ratio is also significant at 63.95%....

Remedium Lifecare Faces Intense Selling Pressure Amid Significant Stock Price Declines

2025-03-28 10:00:12

Remedium Lifecare Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with its stock price dropping by 4.71% in just one day, compared to a modest 0.22% decline in the Sensex. Over the past week, Remedium Lifecare has lost 16.13%, while the Sensex has gained 0.69%. The stock's performance over the last month is particularly concerning, with a staggering 31.58% drop, contrasting sharply with the Sensex's increase of 5.79%. Year-to-date, Remedium Lifecare has plummeted by 64.45%, while the Sensex has only dipped by 0.90%. The stock has now reached a new 52-week and all-time low of Rs. 1.82, reflecting a significant underperformance against its sector by 4%. This marks the fourth consecutive day of losses for Remedium Lifecare, with a total decline of 16.67% during this period. The stock is trading below its 5-day, 2...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

08-Apr-2025 | Source : BSE

Press Release - Remedium Lifecare Announces ?49.19 Cr Rights Issue for Expansion

Board Meeting Outcome for Outcome Of Board Meeting Held On April 07 2025

07-Apr-2025 | Source : BSE

Outcome of Board Meeting held on April 07 2025 for 1)Considering approving and fixing Tuesday 15 April 2025 as the Record Date for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue; 2) Considering and approving the terms of the right issue.